Harnessing the Regenerative Potential of Fetal Mesenchymal Stem Cells and Endothelial Colony‐Forming Cells in the Biofabrication of Tissue‐Engineered Vascular Grafts (TEVGs)
Journal of Tissue Engineering and Regenerative Medicine · 2024
DOI: 10.1155/2024/8707377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Tissue Engineering and Regenerative Medicine, 2024. Verfasst von Angus Weekes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biomedical Technologies, Queensland University of Technology (QUT), Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Tissue Engineering, Blood Vessel Prosthesis, Fetus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Queensland University of Technology, Metro North Hospital and Health Service.
Abstract (Originalsprache)
Tissue engineering is a promising approach for the production of small‐diameter vascular grafts; however, there are limited data directly comparing the suitability of applicable cell types for vessel biofabrication. Here, we investigated the potential of adult smooth muscle cells (SMCs), placental mesenchymal stem cells (MSCs), placental endothelial colony‐forming cells (ECFCs), and a combination of MSCs and ECFCs on highly porous biocompatible poly( ɛ ‐caprolactone) (PCL) scaffolds produced via melt electrowriting (MEW) for the biofabrication of tissue‐engineered vascular grafts (TEVGs). Cellular attachment, proliferation, and deposition of essential extracellular matrix (ECM) components were analysed in vitro over four weeks. TEVGs cultured with MSCs accumulated the highest levels of collagenous components within a dense ECM, while SMCs and the coculture were more sparsely populated, ascertained via histological and immunofluorescence imaging, and biochemical assessment. Scanning electron microscopy (SEM) enabled visualisation of morphological differences in cell attachment and growth, with MSCs and SMCs infiltrating and covering scaffolds completely within the 28‐day culture period. Coverage and matrix deposition by ECFCs was limited. However, ECFCs lined the ECM formed by MSCs in coculture, visualised via immunostaining. Thus, of cells investigated, placental MSCs were identified as the preferred cell source for the fabrication of tissue‐engineered constructs, exhibiting extensive population of porous polymer scaffolds and production of ECM components; with the inclusion of ECFCs for luminal endothelialisation, an encouraging outcome warranting further consideration in future studies. In combination, these findings represent a substantial step toward the development of the next generation of small‐diameter vascular grafts in the management of cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Biomedical Technologies, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
- School of Mechanical, Medical and Process Engineering, Faculty of Engineering, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
- Herston Biofabrication Institute, Metro North Hospital and Health Services, Herston, QLD, Australia.
- Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
- Department of Vascular Surgery, The Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
- School of Biomedical Sciences, Faculty of Health, Queensland University of Technology (QUT), Woolloongabba, QLD, Australia.
ORCID-Profile: Angus Weekes, Joanna M Wasielewska, Nigel Pinto, Jason Jenkins, Jatin Patel, Zhiyong Li, Travis J Klein, Christoph Meinert
Förderung
- Queensland University of Technology
- Metro North Hospital and Health Service
Zitieren
APA
Weekes, A., Wasielewska, J. M., Pinto, N., Jenkins, J., Patel, J., Li, Z., Klein, T. J., & Meinert, C. (2024). Harnessing the Regenerative Potential of Fetal Mesenchymal Stem Cells and Endothelial Colony‐Forming Cells in the Biofabrication of Tissue‐Engineered Vascular Grafts (TEVGs). Journal of Tissue Engineering and Regenerative Medicine. https://doi.org/10.1155/2024/8707377
Vancouver
Weekes A, Wasielewska JM, Pinto N, Jenkins J, Patel J, Li Z, et al. Harnessing the Regenerative Potential of Fetal Mesenchymal Stem Cells and Endothelial Colony‐Forming Cells in the Biofabrication of Tissue‐Engineered Vascular Grafts (TEVGs). Journal of Tissue Engineering and Regenerative Medicine. 2024. doi:10.1155/2024/8707377
BibTeX
@article{Weekes2024,
author = {Weekes, Angus and Wasielewska, Joanna M and Pinto, Nigel and Jenkins, Jason and Patel, Jatin and Li, Zhiyong and Klein, Travis J and Meinert, Christoph},
title = {Harnessing the Regenerative Potential of Fetal Mesenchymal Stem Cells and Endothelial Colony‐Forming Cells in the Biofabrication of Tissue‐Engineered Vascular Grafts (TEVGs)},
journal = {Journal of Tissue Engineering and Regenerative Medicine},
year = {2024},
doi = {10.1155/2024/8707377}
}
EUVIMED